Cargando…
Measuring the impact of cancer: a comparison of non-Hodgkin lymphoma and breast cancer survivors
INTRODUCTION: Self-report instruments such as the Impact of Cancer (IOC) are designed to measure quality of life (QOL) impacts that cancer survivors attribute to their cancer experience. Generalizability of QOL findings across distinct diagnostic categories of survivors is untested. We compare measu...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer US
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2813525/ https://www.ncbi.nlm.nih.gov/pubmed/19967410 http://dx.doi.org/10.1007/s11764-009-0106-1 |
_version_ | 1782176915996540928 |
---|---|
author | Crespi, Catherine M. Smith, Sophia K. Petersen, Laura Zimmerman, Sheryl Ganz, Patricia A. |
author_facet | Crespi, Catherine M. Smith, Sophia K. Petersen, Laura Zimmerman, Sheryl Ganz, Patricia A. |
author_sort | Crespi, Catherine M. |
collection | PubMed |
description | INTRODUCTION: Self-report instruments such as the Impact of Cancer (IOC) are designed to measure quality of life (QOL) impacts that cancer survivors attribute to their cancer experience. Generalizability of QOL findings across distinct diagnostic categories of survivors is untested. We compare measurement of the impact of cancer using the IOC instrument in breast cancer (BC) survivors (n = 1,188) and non-Hodgkin lymphoma (NHL) survivors (n = 652). METHODS: A registry-based sample of NHL survivors completed the IOC questionnaire and the FACT-G, FACT-LYM, Medical Outcomes Study (MOS) SF-36, Post-Traumatic Stress Disorder Checklist-Civilian Version, Post-Traumatic Growth Inventory and MOS Social Support scales. IOC responses of the NHL survivors were subjected to de novo scaling to identify impact domains for comparison to IOC version 2 (IOCv2) domains, which were previously developed based on BC survivor responses. Concurrent validity was assessed by correlating the IOCv2 scales with the other measures. IOCv2 scores were compared between the BC and NHL survivor samples. RESULTS: The BC and NHL survivors exhibited similar impact domains and had factor structures that were largely congruent. The concurrent validity analysis revealed patterns of association that supported the interpretation and validity of the IOCv2 scales. Differences in IOCv2 scores between the BC and NHL groups suggested differential impacts in distinct survivor groups that could be detected using the IOCv2. CONCLUSION: The results suggest that the IOCv2 measures common and important survivor concerns and support its generalizability to the broader long-term cancer survivor population. IMPLICATIONS FOR CANCER SURVIVORS: Instruments such as the IOCv2 can provide valid assessment of QOL impacts in long-term cancer survivors, facilitating the characterization of these impacts and development of appropriate interventions. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s11764-009-0106-1) contains supplementary material, which is available to authorized users. |
format | Text |
id | pubmed-2813525 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-28135252010-02-13 Measuring the impact of cancer: a comparison of non-Hodgkin lymphoma and breast cancer survivors Crespi, Catherine M. Smith, Sophia K. Petersen, Laura Zimmerman, Sheryl Ganz, Patricia A. J Cancer Surviv Article INTRODUCTION: Self-report instruments such as the Impact of Cancer (IOC) are designed to measure quality of life (QOL) impacts that cancer survivors attribute to their cancer experience. Generalizability of QOL findings across distinct diagnostic categories of survivors is untested. We compare measurement of the impact of cancer using the IOC instrument in breast cancer (BC) survivors (n = 1,188) and non-Hodgkin lymphoma (NHL) survivors (n = 652). METHODS: A registry-based sample of NHL survivors completed the IOC questionnaire and the FACT-G, FACT-LYM, Medical Outcomes Study (MOS) SF-36, Post-Traumatic Stress Disorder Checklist-Civilian Version, Post-Traumatic Growth Inventory and MOS Social Support scales. IOC responses of the NHL survivors were subjected to de novo scaling to identify impact domains for comparison to IOC version 2 (IOCv2) domains, which were previously developed based on BC survivor responses. Concurrent validity was assessed by correlating the IOCv2 scales with the other measures. IOCv2 scores were compared between the BC and NHL survivor samples. RESULTS: The BC and NHL survivors exhibited similar impact domains and had factor structures that were largely congruent. The concurrent validity analysis revealed patterns of association that supported the interpretation and validity of the IOCv2 scales. Differences in IOCv2 scores between the BC and NHL groups suggested differential impacts in distinct survivor groups that could be detected using the IOCv2. CONCLUSION: The results suggest that the IOCv2 measures common and important survivor concerns and support its generalizability to the broader long-term cancer survivor population. IMPLICATIONS FOR CANCER SURVIVORS: Instruments such as the IOCv2 can provide valid assessment of QOL impacts in long-term cancer survivors, facilitating the characterization of these impacts and development of appropriate interventions. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s11764-009-0106-1) contains supplementary material, which is available to authorized users. Springer US 2009-12-06 2010 /pmc/articles/PMC2813525/ /pubmed/19967410 http://dx.doi.org/10.1007/s11764-009-0106-1 Text en © The Author(s) 2009 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
spellingShingle | Article Crespi, Catherine M. Smith, Sophia K. Petersen, Laura Zimmerman, Sheryl Ganz, Patricia A. Measuring the impact of cancer: a comparison of non-Hodgkin lymphoma and breast cancer survivors |
title | Measuring the impact of cancer: a comparison of non-Hodgkin lymphoma and breast cancer survivors |
title_full | Measuring the impact of cancer: a comparison of non-Hodgkin lymphoma and breast cancer survivors |
title_fullStr | Measuring the impact of cancer: a comparison of non-Hodgkin lymphoma and breast cancer survivors |
title_full_unstemmed | Measuring the impact of cancer: a comparison of non-Hodgkin lymphoma and breast cancer survivors |
title_short | Measuring the impact of cancer: a comparison of non-Hodgkin lymphoma and breast cancer survivors |
title_sort | measuring the impact of cancer: a comparison of non-hodgkin lymphoma and breast cancer survivors |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2813525/ https://www.ncbi.nlm.nih.gov/pubmed/19967410 http://dx.doi.org/10.1007/s11764-009-0106-1 |
work_keys_str_mv | AT crespicatherinem measuringtheimpactofcanceracomparisonofnonhodgkinlymphomaandbreastcancersurvivors AT smithsophiak measuringtheimpactofcanceracomparisonofnonhodgkinlymphomaandbreastcancersurvivors AT petersenlaura measuringtheimpactofcanceracomparisonofnonhodgkinlymphomaandbreastcancersurvivors AT zimmermansheryl measuringtheimpactofcanceracomparisonofnonhodgkinlymphomaandbreastcancersurvivors AT ganzpatriciaa measuringtheimpactofcanceracomparisonofnonhodgkinlymphomaandbreastcancersurvivors |